Certara Scientists are Among the Topmost Cited Biopharma Researchers
Certara celebrates its 200 published papers and 11 scientists ranked in the top 2% of…
CertaraOctober 20, 2025
Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results
Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…
Danielle PillsburyOctober 15, 2025
MBMA vs. Meta-Analysis: Quick Comparison Guide
Discover how Model-Based Meta-Analysis (MBMA) outperforms traditional meta-analysis in drug development by predicting outcomes, informing…
CertaraOctober 8, 2025
U.S. International Reference Pricing: Global Implications and Pharma Strategy
Unintended global fallout of international reference pricing: How the U.S. Most Favored Nation policy could…
CertaraOctober 6, 2025
Highlights from the FDA Guidance on Dosage Optimization for Therapeutic Radiopharmaceuticals
Learn how radiopharmaceutical therapies work in oncology and how Certara supports development with modeling, simulation,…
CertaraOctober 3, 2025
How Certara and TrialAssure Partner to Deliver Faster, Compliant Anonymization for Global Sponsors
Discover how Certara's partnership with TrialAssure provides global sponsors with accelerated, compliant, and enhanced document…
CertaraOctober 3, 2025
